MidWestOne Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.62M Sell
15,094
-506
-3% -$54.3K 0.21% 111
2025
Q1
$1.57M Buy
15,600
+677
+5% +$68.3K 0.22% 103
2024
Q4
$1.33M Sell
14,923
-789
-5% -$70.5K 0.19% 114
2024
Q3
$1.32M Sell
15,712
-934
-6% -$78.3K 0.18% 119
2024
Q2
$1.28M Sell
16,646
-619
-4% -$47.7K 0.23% 114
2024
Q1
$1.18M Buy
17,265
+168
+1% +$11.5K 0.21% 127
2023
Q4
$988K Buy
17,097
+90
+0.5% +$5.2K 0.19% 135
2023
Q3
$898K Buy
17,007
+1,882
+12% +$99.4K 0.2% 128
2023
Q2
$818K Buy
15,125
+2,249
+17% +$122K 0.18% 146
2023
Q1
$644K Buy
12,876
+797
+7% +$39.9K 0.15% 165
2022
Q4
$559K Buy
12,079
+4,813
+66% +$223K 0.12% 171
2022
Q3
$281K Sell
7,266
-183
-2% -$7.08K 0.07% 197
2022
Q2
$278K Sell
7,449
-621
-8% -$23.2K 0.07% 196
2022
Q1
$357K Sell
8,070
-372
-4% -$16.5K 0.08% 197
2021
Q4
$359K Buy
8,442
+127
+2% +$5.4K 0.08% 195
2021
Q3
$361K Sell
8,315
-387
-4% -$16.8K 0.08% 182
2021
Q2
$372K Sell
8,702
-12,104
-58% -$517K 0.09% 176
2021
Q1
$804K Sell
20,806
-4,213
-17% -$163K 0.19% 116
2020
Q4
$899K Buy
25,019
+9,446
+61% +$339K 0.25% 102
2020
Q3
$595K Sell
15,573
-2,638
-14% -$101K 0.2% 128
2020
Q2
$639K Buy
18,211
+8,955
+97% +$314K 0.27% 73
2020
Q1
$302K Buy
9,256
+333
+4% +$10.9K 0.11% 151
2019
Q4
$403K Sell
8,923
-291
-3% -$13.1K 0.08% 171
2019
Q3
$375K Sell
9,214
-1,105
-11% -$45K 0.12% 162
2019
Q2
$444K Buy
+10,319
New +$444K 0.12% 175